CVS Group plc, a leading provider of integrated veterinary services in the UK, has granted option awards over a total of 140,647 of the company's ordinary shares under the CVS Group Long Term Incentive Plan 2023 (LTIP 17). The options were awarded to certain directors and other employees. The awards will vest in three years' time, subject to performance criteria being satisfied, which include the company's earnings per share growth and total shareholder return over the three-year period between July 1, 2023, and June 30, 2026.
The directors who received option awards are Richard Fairman, Chief Executive Officer, who was granted 34,419 options; Ben Jacklin, Deputy CEO, who was granted 23,757 options; and Robin Alfonso, Chief Financial Officer, who was granted 17,884 options.
The options have an exercise price of 0.2 pence each and were granted off-market on September 29, 2023. The notification and public disclosure of these transactions were made in accordance with the requirements of UK MAR.
No further details or aggregated information about the transactions were provided in the news release.
CVS Group plc can be contacted through Peel Hunt LLP, its nominated adviser and broker, or Camarco, its financial PR firm.